PRIM

Kesehatan

Royal Prima Tbk

Rp121-1(-0,82%)

Open: 122
High: 123
Low: 118
Prev: 122
Volume: 2,36 Jt
Nilai (est.): Rp 285 Jt

Jum, 25 Sep 2026O 122 H 123 L 118 C 121-0,82%Vol 2,36 Jt

RSI (14)57,44Netral

Ringkasan Teknikal

Bullish

MA20

120

+0,75%

MA50

113

+7,19%

RSI(14)

57,44

0 · Oversold3070Overbought · 100

Harga vs MA20Di atasBullish
Harga vs MA50Di atasBullish
MA20 vs MA50Golden (MA20 > MA50)Bullish
RSI(14)NetralNetral

Sinyal dihitung otomatis dari posisi harga terhadap moving average dan level RSI. Hanya sebagai referensi, bukan rekomendasi.

Kinerja Harga

1 Jam

+0,83%

1 Hari

-0,82%

1 Minggu

+0,83%

1 Bulan

+0,83%

3 Bulan

+42,35%

6 Bulan

+75,36%

1 Tahun

+32,97%

Sepanjang Masa

-86,25%

sejak Mei 2018

Terendah 6BTertinggi 6B

65134

Data Fundamental

TTM · Yahoo Finance

Kapitalisasi Pasar: Rp 409 M
P/E Ratio: N/A; EPS negatif
PBV: 0,44x
ROE: -2,02%
EPS: Rp -5,64
Nilai Buku / Saham: Rp 277
Dividend Yield: 0,00%
Saham Beredar: 3,38 M lbr

Tentang Perusahaan

PT Royal Prima Tbk engages in providing hospital services and drugs in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. The company also provides health services, such as inpatient and outpatient medical services, including specialist and sub-specialist care. In addition, the company offers orthopaedic, eye, neurology, internal medicine, obstetrics and gynaecology, heart, lung, Ent-kl, urology. Further, it provides other services, including general surgery, surgical oncology, plastic surgery, pediatric surgery, neurosurgery, digestive surgery, dermatologist and venereologist, psychiatric, dental polyclinic, oral surgery, vascular surgery, kidney and hypertension, endocrine metabolic diabetes. The company was founded in 2013 and is based in Jakarta, Indonesia.

Rata-rata volume 20 hari: 6,62 Jt lembar

Saham Sejenis

Kesehatan